Table 2.
All cancer survivors (n = 391) | Gastric/esophageal (n = 55) | Colorectal (n = 48) | Lung (n = 16) | Breast (n = 70) | Cervical (n = 29) | Prostate (n = 30) | Liver (n = 7) | Other (n = 88) | > One cancer (n = 46) | |
---|---|---|---|---|---|---|---|---|---|---|
Current age, mean (min, max) | 69.1 (23, 95) | 73.2 (25, 93) | 70.8 (38, 95) | 73.6 (61, 85) | 66.9 (40, 85) | 56.7 (28, 85) | 76.7 (58, 93) | 76.2 (61, 85) | 65.2 (23, 91) | 73.5 (46, 94) |
Age at diagnosis, mean (min, max) | 59.1 (17, 90) | 63.3 (25, 85) | 61.7 (37, 79) | 66.9 (51, 83) | 56.9 (36, 83) | 43.9 (20, 70) | 69.7 (48, 87) | 73.1 (58,82) | 54.1 (17, 90) | 61.6 (20, 81) |
Time since diagnosis, N (%) | ||||||||||
≤ 5 years | 162 (42.3) | 19 (35.6) | 24 (48.8) | 9 (53.1) | 26 (36.8) | 12 (43.8) | 17 (60.1) | 6 (83.6) | 31 (37.2) | 17 (39.1) |
6–10 years | 82 (21.3) | 17 (30.0) | 9 (20.1) | 3 (20.6) | 18 (26.8) | 2 (6.5) | 4 (14.2) | 1 (16.4) | 17 (18.5) | 10 (20.7) |
11–15 years | 55 (15.3) | 5 (11.8) | 5 (9.6) | 3 (18.5) | 9 (13.4) | 6 (24.6) | 5 (18.1) | 0 (0.0) | 15 (17.3) | 7 (19.8) |
≥ 16 years | 81 (21.2) | 13 (22.6) | 8 (21.5) | 1 (7.7) | 16 (23.0) | 8 (25.2) | 2 (7.6) | 0 (0.0) | 24 (27.1) | 9 (20.3) |
Health status, N (%) | ||||||||||
Excellent/very good/good | 249 (64.2) | 31 (57.6) | 28 (56.2) | 11 (67.5) | 51 (73.1) | 19 (59.6) | 19 (61.9) | 5 (67.2) | 57 (70.6) | 26 (57.2) |
Fair/poor | 137 (35.8) | 23 (42.4) | 19 (43.8) | 5 (32.5) | 19 (26.9) | 10 (40.4) | 11 (38.1) | 2 (32.8) | 28 (29.4) | 20 (42.8 |
All percentages were adjusted for nonresponse bias by weighting
Two cancer survivors did not indicate their cancer sites